All products featured here are independently selected by our editors and writers. If you buy something through links on our site, Gizmodo may earn an affiliate commission. Reading time 7 minutes ...
Curious about when Blue Lock Chapter 334 is coming out? The series is racing into yet another high-energy chapter, loaded with fierce rivalries, smart plays, and moments that could completely shake ...
No bulk or screen; looks like a regular lock from both sides of the door. Impressive design with the battery hidden inside the lock bolt. Great battery life. App is beautiful and easy to use. More ...
For the past decade, I’ve been renting an apartment. For even longer, I’ve been a fan and adopter of smart home tech. That means I’ve been counting down the days until I could finally escape my ...
For the past two weeks, I’ve been unlocking my front door without ever touching a keypad, fingerprint reader, smartphone, or physical key, thanks to a new smart lock. It’s the first lock I’ve ...
Powered by wireless optical charging tech, Lockin's $1,300 V7 Max smart lock is a glimpse at the future of home security. I’m PCMag’s senior writer covering smart home and wearable devices. I’ve been ...
Forbes contributors publish independent expert analyses and insights. Zak Doffman writes about security, surveillance and privacy. This is not as easy as it sounds — and it’s not common advice. But ...
Wyze upgrades its smart deadbolt with Wi-Fi and a new look — but keeps the rock bottom price tag about the same. Three years ago, Wyze did what Wyze does best, introducing a capable smart lock that ...
The popular bangle timepiece with interchangeable bezels has been renamed the Play. By Joshua Hendren A Gucci watch, popular in the 1990s for its interchangeable plastic bezels in a range of bright ...
Please provide your email address to receive an email when new articles are posted on . Poherdy (pertuzumab-dpzb, Shanghai Henlius Biologics Co.), a HER2 receptor antagonist and biosimilar to ...
Poherdy is the first interchangeable biosimilar to Perjeta, approved for HER2-positive breast cancer, expanding access to targeted therapies. Biosimilars like Poherdy meet rigorous FDA standards, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results